VIVUS, Inc. (VVUS) Financial Statements (2024 and earlier)

Company Profile

Business Address 900 E. HAMILTON AVENUE
CAMPBELL, CA 95008
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2020
MRQ
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 32,649111,520226,943270,134241,825299,599
Cash and cash equivalents 32,64930,41166,39284,78395,39583,174
Short-term investments  80,838159,943184,736146,168216,397
Other undisclosed cash, cash equivalents, and short-term investments  27160861526228
Receivables 22,33825,60812,1879,4788,99711,595
Inventory, net of allowances, customer advances and progress billings 33,67923,13217,71216,18613,60234,447
Inventory 33,67923,13217,71216,18613,60234,447
Prepaid expense 3,2252,2301,1241,1821,1241,612
Deferred costs     1,1941,246
Other undisclosed current assets 4,9095,0375,4466,4548,0449,938
Total current assets: 96,800167,527263,412303,434274,786358,437
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 354
Operating lease, right-of-use asset 781
Property, plant and equipment 2333415427889941,346
Deferred costs     2,1853,375
Other noncurrent assets     2,6163,780
Other undisclosed noncurrent assets 120,140134,2791,0141,554 (1,346)
Total noncurrent assets: 121,508134,6201,5562,3425,7957,155
Other undisclosed assets      1,346
TOTAL ASSETS: 218,308302,147264,968305,776280,581366,938
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 40,12441,96531,54720,39322,95134,618
Interest and dividends payable      2,921
Employee-related liabilities      4,230
Accounts payable 7,7268,92110,0724,7077,06010,430
Accrued liabilities 32,39833,04421,47515,68615,89117,037
Deferred revenue 1,249
Debt 183,773 5,1478,70815,55010,459
Restructuring reserve      3,284
Deferred revenue and credits2,07519,17422,14219,445
Other undisclosed current liabilities  1,235   (10,435)
Total current liabilities: 225,14643,20038,76948,27560,64357,371
Noncurrent Liabilities
Long-term debt and lease obligation 59,323294,446230,536232,610219,219217,324
Long-term debt, excluding current maturities 58,721294,446230,536232,610219,219217,324
Finance lease, liability 136
Liabilities, other than long-term debt 3,0632345,0016,7067,80410,225
Deferred revenue and credits4,6746,4496,5088,876
Accounts payable and accrued liabilities  2343272571,296849
Deferred revenue 3,063
Restructuring reserve      500
Operating lease, liability 466
Other undisclosed noncurrent liabilities  4,290   (500)
Total noncurrent liabilities: 62,386298,970235,537239,316227,023227,049
Total liabilities: 287,532342,170274,306287,591287,666284,420
Equity
Equity, attributable to parent (69,224)(40,023)(9,338)18,185(7,085)82,518
Common stock 1111105105104104
Additional paid in capital 842,808840,751834,730831,750829,428825,691
Accumulated other comprehensive loss (35)(270)(608)(616)(261)(28)
Accumulated deficit (912,008)(880,515)(843,565)(813,054)(836,356)(743,249)
Total equity: (69,224)(40,023)(9,338)18,185(7,085)82,518
TOTAL LIABILITIES AND EQUITY: 218,308302,147264,968305,776280,581366,938

Income Statement (P&L) ($ in thousands)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 69,76065,06265,373124,25895,430114,181
Revenue, net65,373124,25895,430114,181
Cost of revenue
(Cost of Goods and Services Sold)
 (15,671)(14,613)(17,187)(10,602)(29,522)(35,557)
Gross profit: 54,08950,44948,186113,65665,90878,624
Operating expenses (65,058)(68,541)(62,580)(68,573)(155,707)(164,892)
Other undisclosed operating income  14,61317,18710,60229,52235,557
Operating income (loss): (10,969)(3,479)2,79355,685(60,277)(50,711)
Nonoperating expense (20,513)(33,419)(33,302)(32,313)(32,827)(32,565)
Interest and debt expense (11)1,427(33,231)(32,888)(33,317) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 11(1,427)33,23132,88833,317 
Income (loss) from continuing operations before income taxes: (31,482)(36,898)(30,509)23,372(93,104)(83,276)
Income tax expense (benefit) (21)(52)(2)(70)(3)629
Income (loss) from continuing operations: (31,503)(36,950)(30,511)23,302(93,107)(82,647)
Income (loss) before gain (loss) on sale of properties: (31,503)(36,950)(30,511)23,302(93,107)(82,647)
Net income (loss) available to common stockholders, diluted: (31,503)(36,950)(30,511)23,302(93,107)(82,647)

Comprehensive Income ($ in thousands)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (31,503)(36,950)(30,511)23,302(93,107)(82,647)
Comprehensive income (loss): (31,503)(36,950)(30,511)23,302(93,107)(82,647)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 2353388(355)(233)(94)
Comprehensive income (loss), net of tax, attributable to parent: (31,268)(36,612)(30,503)22,947(93,340)(82,741)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: